Behavior of the radioiodine thyroid test after treatment with HCG
Salvia, A.; Licata, G.
Bollettino della Societa Italiana di Biologia Sperimentale 47(10): 285-288
1971
ISSN/ISBN: 0037-8771 PMID: 5110168 Document Number: 33683
Document emailed within 1 workday
Related Documents
Górowski, T.; Gabryelewicz, M.B.; Jastrzebska, H. 1992: Anaplastic thyroid carcinoma developed after treatment of "hot" thyroid nodule with radioiodine Endokrynologia Polska 43(3): 308-313Nüchel, C.; Boddenberg, B.; Schicha, H. 1993: The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases Nuklearmedizin. Nuclear Medicine 32(2): 91-98
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307
Dirr, W.; Pabst, H.W. 1982: Treatment of follicular thyroid cancer with radioiodine Schweizerische Rundschau für Medizin Praxis 71(13): 562-566
Schachter, D.; Atria, A.; Pineda, G. 1986: The autonomous thyroid nodule: results of treatment with radioiodine Revista Medica de Chile 114(3): 228-231
Roldán Schilling, V.; Fernández Abellán, P.; Domínguez Escribano, J.R.; Rivas González, C.; Mut Barberá, E.; Calatayud Cendra, R. 1998: Acute leukemias after treatment with radioiodine for thyroid cancer Haematologica 83(8): 767-768
Konrády, Aás. 2002: Radioiodine treatment of differentiated thyroid carcinomas: residual ablation Orvosi Hetilap 143(25): 1557; Author Reply
Łabuzek, K.; Kukla, U.; Chronowska, J.; Madej, P.ł; Okopień Bogusław 2014: Radioiodine--today's trends in treatment of benign thyroid diseases Wiadomosci Lekarskie 67(2 Part 1): 80-84
Bednár, J.; Nĕmec, J.; Soutorová, M.; Neradilová, M.; Pohunková, D.; Zamrazil, V.; Vána, S.; Havelka, J.; Röhling, S. 1979: Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment Endocrinologia Experimentalis 13(1): 53-63
Schober, O.; Günter, H.H.; Schwarzrock, R.; Hundeshagen, H. 1987: Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 163(7): 464-474
Thientunyakit, T.; Pusuwan, P.; Tuchinda, P.; Khiewvan, B.; Kiewvan, B. 2013: The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation Journal of the Medical Association of Thailand 96(9): 1199-1207
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450
Ursu, H.I.; Dumitriu, L.; Grigorie, D.; Simescu, M.; Vaida, E.; Belgun, M.; Popovici, D. 1993: Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease) Romanian Journal of Endocrinology 31(3-4): 155-163
Bałdys-Waligórska, A.; Gołkowski, F.; Krzentowska-Korek, A.; Hubalewska-Dydejczyk, A. 2010: Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal Endokrynologia Polska 61(5): 474-479
Grudeva-Popova, J.; Yaneva, M.; Zisov, K.; Ananoshtev, N. 2007: Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 129-132
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Borde, C.; Basu, S.; Kand, P.; Arya, S.; Shet, T. 2011: Bilateral renal metastases from papillary thyroid carcinoma on post 131i treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation Hellenic Journal of Nuclear Medicine 14(1): 72-73
Horácek, Jí. 2015: Radioiodine therapy in patients with low-thyroid cancer Vnitrni Lekarstvi 61(9): 755-757
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238
Beckers, C. 1999: Radioiodine and thyroid-associated ophthalmopathy: from the myth to the reality Journal of Endocrinological Investigation 22(9): 705-707